The nation of Zimbabwe has declined a substantial American health deal valued at 367 million US dollars (£272m) over five years because of the United States' insistence on sensitive information.
The decision became public after a government memo from December was leaked, indicating that Head of State Emmerson Mnangagwa believed the agreement was "skewed".
An official representative later stated that the United States was demanding access to health data for research and profit while refused to guarantee the resulting advantages from any future medical innovations.
"We will now turn to the challenging and unfortunate process of scaling back our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had furnished over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has appealed for further talks to reach a agreement agreeable to all parties so the country's critical HIV treatment initiative can continue.
Wider Background
This development comes after a comparable situation in neighbouring Kenya, where a high court suspended a related deal with the US following concerns were raised about the security of citizens' health data.
After resuming office last year, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
USAID had administered aid for the US government, but Trump claimed its expenditure was "inefficient" and his government was seeking government-to-government deals to enhance openness and accountability.
According to reports, Sixteen nations in Africa have to date agreed to similar health pacts, representing more than $18.3bn of fresh investment.
Specifics of the Rejected Agreement
The funds for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this partnership could have provided significant advantages for the people of Zimbabwe, especially the 1.2 million currently receiving antiretroviral therapy through American-funded initiatives," Tremont commented.
However, official spokesman Nick Mangwana said the proposed deal was "unequal".
"Our nation was requested to share its biological resources and data for a long time, without any equivalent promise of benefiting from any scientific breakthroughs – like new medicines or tests – that might be developed from that shared data," his statement read.
"Put simply, our nation would provide the raw materials for scientific discovery with no certainty that the final treatments would be accessible to our citizens if a future pandemic arise."
Sovereignty and Global Health
He also noted that the American exit from the global health body and its pursuit of one-on-one health agreements were disrupting frameworks already established through the global health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to manage potential global health emergencies.
"This mechanism is designed to guarantee that when a country contributes its samples, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the capability to develop them."
The government's concerns over the US deal "must not be interpreted as anti-American sentiment," he added.
"We welcome ongoing dialogue with our American counterparts on how subsequent collaboration might be arranged in a way that honours the independence and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but suggested that talks must proceed considering a large portion of the nation's Aids initiatives were funded by foreign aid.
"In cases where specific concerns exist, such as those involving data governance or implementation frameworks, these can frequently be addressed through detailed discussion and mutually agreed protections," the group said.
The halted deal highlights the complex tensions between receiving vital international aid and protecting national sovereignty in an ever more data-driven world.